Please login to the form below
Tiziana Life Sciences appoints clinical sciences VP
Dr Robert Evans joins the UK biotechnology firm
London-based Tiziana Life Sciences has appointed Dr Robert Evans as its new vice president of clinical sciences.
Dr Evans joins the clinical stage biotechnology company from Glenmark Pharmaceuticals, where he also served as vice president of clinical sciences.
In that role, he was responsible for providing project and clinical leadership across multiple programmes focused on the treatment of oncology, respiratory and dermatology disorders.
Prior to this, Dr Evans held a number of scientific leadership positions while at Amgen, Johnson & Johnson and Regeneron.
James Tripp, chief operating officer at Tiziana Life Sciences, said: “Bob's extensive background in the clinical development industry… combined with his strong background in immunology and oncology adds tremendous support to our exciting portfolio.
“I am very confident that together with out impressive pipeline and strong team we will continue to drive the company forward to significant future success.”
Subscribe to our email news alerts
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
- Landscape review reveals £1.1bn of UK funding for rare diseases
No results were found
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
